About the Authors

Charles Lu

clu@mdanderson.org

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

David J. Stewart

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

J. Jack Lee

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Lin Ji

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Rajagopal Ramesh

Affiliation University of Oklahoma Health Sciences Center and Stephenson Cancer Center, Oklahoma City, Oklahoma, United States of America

Gitanjali Jayachandran

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Maria I. Nunez

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Ignacio I. Wistuba

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Jeremy J. Erasmus

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Marshall E. Hicks

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Elizabeth A. Grimm

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

James M. Reuben

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Veerabhadran Baladandayuthapani

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Nancy S. Templeton

Affiliation Gradalis Inc, Carrollton, Texas, United States of America

John D. McMannis

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Jack A. Roth

Affiliation The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

Competing Interests

CL: Patent-TUSC2 Therapeutic Response Markers (pending), Co-Inventor JAR: Consultancy, grants, stock: Genprex, Inc.; Patents pending and issued: TUSC2/FUS1 NST: Novel DNA:liposome complexes for increased systemic delivery and gene expression. United States Letters Patent No. 6,413,544 B1 issued July 2, 2002. United States Patent No. 6,770,291 B2 issued August 3, 2004. International Publication Number: WO 98/07408. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: CL DJS JJL LJ GJ MIN IIW EAG JMR JAR. Performed the experiments: CL DJS LJ GJ MIN IIW JMR JDM. Analyzed the data: CL DJS JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB. Contributed reagents/materials/analysis tools: JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB JDM. Wrote the paper: CL DJS JJL LJ RR GJ MIN IIW JJE MEH EAG JMR VB NST JAR.